SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-12-003431
Filing Date
2012-01-05
Accepted
2012-01-05 15:26:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT d270638d424b5.htm 424B5 526220
2 GRAPHIC g270638synageva_pmscolor.jpg GRAPHIC 28013
  Complete submission text file 0001193125-12-003431.txt   566079
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-178653 | Film No.: 12510842
SIC: 2836 Biological Products, (No Diagnostic Substances)